Circular RNA circ‐FIRRE interacts with HNRNPC to promote esophageal squamous cell carcinoma progression by stabilizing GLI2 mRNA
Cancer Science · 2023-09 · 114 (9) · 3608-3622
DOI: 10.1111/cas.15899 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, online erschienen am 07.07.2023. Verfasst von Yongjia Zhou und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, The Second Hospital of Shandong University, Jinan, China. Hauptthemen laut MEDLINE: Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms, MicroRNAs. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: the Special Construction Project Fund for Taishan Mountain Scholars of Shandong Province and Jinan Clinical Medicine Research.
Abstract (Originalsprache)
Increasing evidence has shown that circular RNAs (circRNAs) interact with RNA‐binding proteins (RBPs) and promote cancer progression. However, the function and mechanism of the circRNA/RBP complex in esophageal squamous cell carcinoma (ESCC) are still largely unknown. Herein, we first characterized a novel oncogenic circRNA, circ‐FIRRE, by RNA sequencing (Ribo‐free) profiling of ESCC samples. Furthermore, we observed marked circ‐FIRRE overexpression in ESCC patients with high TNM stage and poor overall survival. Mechanistic studies indicated that circ‐FIRRE, as a platform, interacts with the heterogeneous nuclear ribonucleoprotein C (HNRNPC) protein to stabilize GLI2 mRNA by directly binding to its 3’‐UTR in the cytoplasm, thereby resulting in elevated GLI2 protein expression and subsequent transcription of its target genes MYC , CCNE1 , and CCNE2 , ultimately contributing to ESCC progression. Moreover, HNRNPC overexpression in circ‐FIRRE knockdown cells notably abolished circ‐FIRRE knockdown‐mediated Hedgehog pathway inhibition and ESCC progression impairment in vitro and in vivo. Clinical specimen results showed that circ‐FIRRE and HNRNPC expression was positively correlated with GLI2 expression, which reveals the clear significance of the circ‐FIRRE/HNRNPC‐GLI2 axis in ESCC. In summary, our results indicate that circ‐FIRRE could serve as a valuable biomarker and potential therapeutic target for ESCC and highlight a novel mechanism of the circ‐FIRRE/HNRNPC complex in ESCC progression regulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thoracic Surgery, The Second Hospital of Shandong University, Jinan, China.
- Department of Pharmacy, The Second Hospital of Shandong University, Jinan, China.
- Institute of Medical Sciences, The Second Hospital of Shandong University, Jinan, China.
- Key Laboratory of Thoracic Cancer in Universities of Shandong, The Second Hospital of Shandong University, Jinan, China.
ORCID-Profile: Xiaogang Zhao
Förderung
- the Special Construction Project Fund for Taishan Mountain Scholars of Shandong Province and Jinan Clinical Medicine Research
Zitieren
APA
Zhou, Y., Xue, X., Luo, J., Li, P., Xiao, Z., Zhang, W., Zhou, J., Li, P., Zhao, J., Ge, H., Tian, Z., & Zhao, X. (2023). Circular RNA circ‐FIRRE interacts with HNRNPC to promote esophageal squamous cell carcinoma progression by stabilizing GLI2 mRNA. Cancer Science, 114(9), 3608-3622. https://doi.org/10.1111/cas.15899
Vancouver
Zhou Y, Xue X, Luo J, Li P, Xiao Z, Zhang W, et al. Circular RNA circ‐FIRRE interacts with HNRNPC to promote esophageal squamous cell carcinoma progression by stabilizing GLI2 mRNA. Cancer Science. 2023;114(9):3608-3622. doi:10.1111/cas.15899
BibTeX
@article{Zhou2023,
author = {Zhou, Yongjia and Xue, Xia and Luo, Junwen and Li, Peiwei and Xiao, Zhaohua and Zhang, Wenhao and Zhou, Jie and Li, Peichao and Zhao, Jiangfeng and Ge, Haibo and Tian, Zhongxian and Zhao, Xiaogang},
title = {Circular RNA circ‐FIRRE interacts with HNRNPC to promote esophageal squamous cell carcinoma progression by stabilizing GLI2 mRNA},
journal = {Cancer Science},
year = {2023},
volume = {114},
number = {9},
pages = {3608--3622},
doi = {10.1111/cas.15899}
}
EUVIMED